QIAGEN N.V. Shareholders Approve Return Of Approximately $250 Million In Cash To Shareholders Via Synthetic Share Repurchase
Following the announcement of the synthetic share repurchase plan in August 2016, shareholders at an Extraordinary General Meeting of Shareholders (EGM) today approved all three proposals to amend the Company's Articles of Association to allow for an adjustment in QIAGEN's share capital in order to complete the related capital repayment. Similar approaches have previously been used by other large, multinational Dutch companies as an efficient way to provide returns to all shareholders, and to do so in a faster and more efficient way than through a traditional open-market share repurchase program.
The transactions are expected to be completed in early January 2017 following the expiration of a two-month creditor objection period, which is required by Dutch law and begins after filing of the EGM resolution with the Dutch Trade Register and publication in a Dutch daily newspaper.
Click here for full press release
Contacts:
QIAGEN
Investor Relations
John Gilardi
ir@QIAGEN.com
+49-2103-29-11711
Public Relations
Dr. Thomas Theuringer
pr@QIAGEN.com
+49-2103-29-11826
SOURCE QIAGEN N.V.